IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc RIIb cross-linking
Open Access
- 1 March 2006
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 116 (3), 833-841
- https://doi.org/10.1172/jci25575
Abstract
Although it has long been hypothesized that allergen immunotherapy inhibits allergy, in part, by inducing production of IgG Abs that intercept allergens before they can cross-link mast cell FcεRI-associated IgE, this blocking Ab hypothesis has never been tested in vivo. In addition, evidence that IgG-allergen interactions can induce anaphylaxis by activating macrophages through FcγRIII suggested that IgG Ab might not be able to inhibit IgE-mediated anaphylaxis without inducing anaphylaxis through this alternative pathway. We have studied active and passive immunization models in mice to approach these issues and to determine whether any inhibition of anaphylaxis observed was a direct effect of allergen neutralization by IgG Ab or an indirect effect of cross-linking of FcεRI to the inhibitory IgG receptor FcγRIIb. We demonstrate that IgG Ab produced during the course of an immune response or administered passively can completely suppress IgE-mediated anaphylaxis; that these IgG blocking Abs inhibit IgE-mediated anaphylaxis without inducing FcγRIII-mediated anaphylaxis only when IgG Ab concentration is high and challenge allergen dose is low; that allergen epitope density correlates inversely with the allergen dose required to induce both IgE- and FcγRIII-mediated anaphylaxis; and that both allergen interception and FcγRIIb-dependent inhibition contribute to in vivo blocking Ab activity.Keywords
This publication has 53 references indexed in Scilit:
- Targeting the IgE molecule in allergic and asthmatic diseases: Review of the IgE molecule and clinical efficacyJournal of Allergy and Clinical Immunology, 2005
- Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor β2 chain expression in patients with allergic asthmaCellular Immunology, 2004
- GADOLINIUM CHLORIDE ALTERS THE ACINAR DISTRIBUTION OF PHAGOCYTOSIS AND BALANCE BETWEEN PRO- AND ANTI-INFLAMMATORY CYTOKINESShock, 1996
- Augmented humoral and anaphylactic responses in FcγRII-deficient miceNature, 1996
- Inhibition of anaphylactic shock by gadolinium chloride-induced Kupffer cell blockadeInflammation Research, 1994
- Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapyJournal of Allergy and Clinical Immunology, 1992
- IgG and IgE Antibodies after Immunotherapy with Bee and Wasp VenomInternational Archives of Allergy and Immunology, 1989
- Venom‐specific IgE and IgG antibodies as a measure of the degree of protection in insect‐sting‐sensitive patientsClinical and Experimental Allergy, 1983
- Thirteen hybridomas secreting hapten‐specific immunoglobulin E from mice with Iga or Igb heavy chain haplotypeEuropean Journal of Immunology, 1981
- Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.The Journal of Experimental Medicine, 1979